Skip to main navigation Skip to search Skip to main content

Continuous manufacturing and process analytical technology: focusing on dosage forms with improved solubility and controlled release

  • Su Hyun Seok
  • , Seung Dong Yoo
  • , Dong‑Wook Kim
  • , In Ah Lee
  • , Kyung Hyun Min
  • , Ji Hyun Kang
  • , Chun Woong Park
  • , Ju Young Kim*
  • , Eun Seok Park*
  • *Corresponding author for this work
  • Sungkyunkwan University
  • Wonkwang University
  • Kunsan National University
  • Chungbuk National University
  • Woosuk University

Research output: Contribution to journalReview articlepeer-review

Abstract

Background: The implementation of continuous manufacturing (CM) processes has become a significant trend in the advancement of the pharmaceutical industry. Reports have demonstrated that conventional batch processes, such as blending, granulation, and tableting, have been successfully integrated into the CM process. Studies have also indicated that using appropriate process analytical technology (PAT) tools enhances product quality within the CM process. Area covered: Solubility enhancement and drug release control have been traditionally considered high-demand and valuable technologies in the pharmaceutical industry. This article reviews recent approaches in CM and PAT research relating to these technologies. Expert opinion: Pharmaceutical processes such as hot-melt extrusion, coating, spray-drying, electrospinning, and milling are integrated into CM process and are employed for solubility enhancement or drug release control. A single continuous process machine is considered a suitable candidate for integration into the CM process. Examples of such machines include hot-melt extruders and continuous coaters. Many studies have applied PAT to CM, however most of them have focused on immediate-release formulations. This review strives to comprehensively elucidate various cases of CM processes utilizing real-time PAT tools. Their promising results are expected to contribute to the expanded applicability of CM processes.

Original languageEnglish
Article number119343
Pages (from-to)463-479
Number of pages17
JournalJournal of Pharmaceutical Investigation
Volume55
Issue number3
DOIs
StatePublished - 2025.05

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Keywords

  • Continuous manufacturing process
  • Controlled drug release
  • Critical quality attribute
  • Process analytical technology
  • Solubility enhancement

Quacquarelli Symonds(QS) Subject Topics

  • Pharmacy & Pharmacology

Fingerprint

Dive into the research topics of 'Continuous manufacturing and process analytical technology: focusing on dosage forms with improved solubility and controlled release'. Together they form a unique fingerprint.

Cite this